Riskpilot← Back to searchSign inGet full accessOcularist Müller AB
ABActiveOrg 5568534431Vikingagatan 26Manufacture of medical and dental instruments and supplies · NACE 3250Est. 20112 employees
Revenue 2024
SEK 970K
+6% vs 2023
EBITDA margin
-137.3%
+6% vs 2023
Equity ratio
97.6%
Financial strength
Net profit 2024
SEK 8,6M
+142% vs 2023
| Revenue | SEK 970K | +6% |
| EBITDA | SEK -1,3M | +6% |
| Net profit | SEK 8,6M | +142% |
| Total assets | SEK 37,6M | +16% |
| Equity | SEK 36,7M | +26% |
| Employees | 2 | — |
Legal name
Ocularist Müller AB
Org number
5568534431
Legal form
Aktiebolag
NACE code
3250 · Manufacture of medical and dental instruments and supplies
Founded
19 maj 2011
Share capital
SEK 50 050
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget ska bedriva okularistverksamhet i Sverige och utomlands, innefattande utveckling, tillverkning och försäljning av ögon- proteser samt därmed förenlig verksamhet.
Address
Vikingagatan 26
Email
leif@ljung.name
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 621 | 1 057 | 873 | 913 | 970 |
| Staff expenses | — | — | −1 992 | −2 255 | −2 328 |
| EBITDA | −1 388 | −980 | −1 152 | −1 414 | −1 332 |
| Depreciation & amort. | −0 | −0 | — | −2 | −4 |
| EBIT | −1 388 | −980 | −1 152 | −1 416 | −1 336 |
| Net financials | 7 777 | 3 782 | 6 137 | 7 117 | 7 610 |
| Profit before tax | 6 389 | 2 801 | 5 835 | 4 750 | 8 224 |
| Tax | −162 | 400 | −707 | −1 177 | 424 |
| Net profit | 6 227 | 3 201 | 5 128 | 3 574 | 8 648 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 21 834 | 24 275 | 27 657 | 32 514 | 37 559 |
| Equity | 19 707 | 22 123 | 26 371 | 29 024 | 36 658 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 276 | 302 | 286 | 1 541 | 901 |
| Total debt | 276 | 302 | 286 | 1 541 | 901 |
EBITDA margin
-137.3%
This company
15.8%
Market median
-969% vs market
20202024
Equity ratio
97.6%
This company
38.2%
Market median
+155% vs market
20202024
Return on equity
23.6%
This company
18.4%
Market median
+28% vs market
20202024
Net profit margin
891.8%
This company
8.1%
Market median
+10910% vs market
20202024
Asset turnover
0.03×
This company
1.12×
Market median
-97% vs market
20202024
Debt / equity
0.02×
This company
0.62×
Market median
+97% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Ocularist Müller AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Leif Göran Ljung | Deputy Board Member | 0 companies |
| Ann-Charlotte Müller-Uri | Board of Directors | 0 companies |